The Department determined that a new rule is needed to implement the statute requiring the program manager to work with the stakeholders to develop a rule to identify the indicators of controlled substance abuse.

DEPARTMENT OF HEALTH
Prescription Drug Monitoring Program

RULE NO.: RULE TITLE:
64K-1.007: Indicators of Substance Abuse
PURPOSE AND EFFECT: The Department determined that a new rule is needed to implement the statute requiring the program manager to work with the stakeholders to develop a rule to identify the indicators of controlled substance abuse.
SUBJECT AREA TO BE ADDRESSED: Indicators of Substance Abuse.
RULEMAKING AUTHORITY: 893.055 FS.
LAW IMPLEMENTED: 893.055 FS.
A RULE DEVELOPMENT WORKSHOP WILL BE HELD AT THE DATE, TIME AND PLACE SHOWN BELOW:
DATE AND TIME: December 1, 2011, 9:00 a.m.
PLACE: Orlando Airport Marriott, 7499 Augusta National Drive, Orlando, Florida 32822
Pursuant to the provisions of the Americans with Disabilities Act, any person requiring special accommodations to participate in this workshop/meeting is asked to advise the agency at least 5 days before the workshop/meeting by contacting: telephone number [phone]. If you are hearing or speech impaired, please contact the agency using the Florida Relay Service, 1(800)955-8771 (TDD) or 1(800)955-8770 (Voice).
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca R. Poston, BPharm, RPh., Program Manager, 4052 Bald Cypress Way, Bin #C-16, Tallahassee, Florida 32399, telephone number [phone]

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.